Efficacy and Safety of Lenalidomide (Len) Versus Placebo (Pbo) in Rbc-Transfusion Dependent (Td) Patients (Pts) with Ipss Low/Intermediate (Int-1)-Risk Myelodysplastic Syndromes (Mds) Without Del(5Q) and Unresponsive or Refractory to Erythropoiesis-Stimulating Agents (Esas): Results from a Randomized Phase 3 Study (Cc-5013-Mds-005)

AuthID
 P-00A-8BQ
20
Author(s)
Santini, V
·
Giagounidis, A
·
Vey, N
·
Mufti, GJ
·
Buckstein, R
·
Mittelman, M
·
Platzbecker, U
·
Shpilberg, O
·
Ram, R
·
del Canizo, C
·
Gattermann, N
·
Ozawa, K
·
Zhong, J
·
Seguy, F
·
Hoenekopp, A
·
Beach, CL
·
Fenaux, P
Document Type
Abstract
Year published
2014
Published
in BLOOD, ISSN: 0006-4971
Volume: 124, Issue: 21
Conference
56Th Annual Meeting of the American-Society-Of-Hematology, Date: DEC 06-09, 2014, Location: San Francisco, CA, Sponsors: Amer Soc Hematol
Indexing
Wos®
Publication Identifiers
Wos: WOS:000349233804048
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Marked List
 Add to Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service